Interestingly, the level of myeloperoxidase was increased, and treatment with an inhibitor of myeloperoxidase throughout the entire 26 weeks reduced the incidence of spontaneous MI and stroke in these mice.22 However, the authors did not investigate whether a treatment applied at reperfusion could reduce infarct size. The gene discussed is MPO; the disease is Stroke.